Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Open Access
- 1 December 2025
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research Communications
- Vol. 5 (12) , 2102-2111
Abstract
Neuronal autoantibodies have been identified in immune-mediated encephalitis, most of which are related to paraneoplastic neurologic syndromes (PNS). We detected neuronal autoantibodies in patients with gastric cancer without PNS and illustrated their correlation with clinical prognosis. All serum samples were tested by the mouse brain tissue-based assay (TBA) using immunofluorescence for screening neuronal autoantibodies. Known PNS-related neuronal autoantibodies were detected by cell-based assay. A single-center cohort has been started in Nanfang Hospital. The T-cell status of the tumor microenvironment was assessed. Single-cell sequencing was performed with limited tumor samples. Patients were grouped into TBA-positive (n = 144) and TBA-negative (n = 179) groups by the TBA status. Further screening of TBA+ specimens using the cell-based assay method revealed known PNS-related autoantibodies in 13.2% (19/144) of cases. Additionally, TBA-positive patients with gastric cancer exhibited lower CD8+ T-cell infiltration in the tumor tissue. The survival analysis show that neuronal autoantibodies in patients (TBA-positive) were associated with shorter overall survival (OS; P = 0.014). In the multivariate survival analysis, TBA positivity was still associated with shortened OS after adjusting the major covariates (HR = 2.28; 95% confidence interval, 1.31–3.97; P = 0.004). Meanwhile, single-cell sequencing indicates that cell junction assembly and synapse organization may play important roles in biological process. In this cohort study, neuronal autoantibodies were highly prevalent among patients with gastric cancer and were associated with shortened OS and features of immunosuppression within the tumor microenvironment, suggesting a candidate for exploring therapeutic relevance, with further mechanistic studies needed for validation. Significance: Neuronal autoantibodies are prevalent in patients with gastric cancer, and patients without neurologic symptoms are linked to shorter survival and immunosuppression. These results provide a new direction for prognostic biomarkers and targeted therapy exploration.Keywords
All Related Versions
Funding Information
- Nanfang Hospital (2021CR003)
- Special Project for Research and Development in Key areas of Guangdong Province (2023B1111050009)
- National Natural Science Foundation of China (#82272991)
This publication has 35 references indexed in Scilit:
- Potentiating anti-tumor immunity by re-engaging immune synapse moleculesCell Reports Medicine, 2025
- Anti-CRMP2 antibody induces anxiety-like behavior and increases pyramidal neuron excitability in miceBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024
- Crosstalk between the nervous system and tumor microenvironment: Functional aspects and potential therapeutic strategiesCancer Letters, 2024
- Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung CancerJAMA Oncology, 2021
- Anti-GABAB receptor encephalitis in a patient with gastric adenocarcinomaNeurological Sciences, 2018
- Paraneoplastic Neurologic SyndromesNeurologic Clinics, 2018
- Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic SignalingCancer Cell, 2017
- Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of ThymomaJAMA Neurology, 2016
- Onconeural antibodies in sera from patients with various types of tumoursCancer Immunology, Immunotherapy, 2009
- Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patientsJournal of Neurology, 1997